Search

The ever-growing need for radiopharmaceuticals, i.e., compounds containing pharmaceutical drugs and radioisotopes used for medical diagnostic imaging (SPECT/PET scan) and treating neoplasms, is significantly leading to an increased demand for such substances in hospitals and clinics worldwide. Currently, most large-scale productions of radioisotopes required for radiopharmaceuticals are carried out in research reactors, via the fission of highly enriched uranium. However, because large amounts of radioactive waste are produced as byproducts in this process, new greener methods are needed for radioisotope production. This work presents an integrative literature review and summarizes enriched uranium-free methods for radioisotope production, accomplished through the adoption of new reaction routes, distinct acceleration technologies, or by using other physical processes. This review considered forty-eight studies published from 2010 to 2021 on three established virtual databases. Among these selected works, a cyclotron is the most adopted HEU-free method for radioisotope production, and 44 Sc, 68 Ga, and 99 m Tc are the medical radioisotopes most often reported as produced by using the investigated HEU-free production methods. [ABSTRACT FROM AUTHOR]

Plasma wakefields driven by high power lasers or relativistic particle beams can be orders of magnitude larger than the fields produced in conventional accelerating structures. Since the plasma wakefield is composed not only of accelerating but also of decelerating phases, this paper proposes to utilize the strong decelerating field induced by a laser pulse in the plasma to absorb the beam energy, in a scheme known as the active plasma beam dump. The design of this active plasma beam dump has considered the beam output by the EuPRAXIA facility. Analytical estimates were obtained, and compared with particle-in-cell simulations. The obtained results indicate that this active plasma beam dump can contribute for more compact, safer, and greener accelerators in the near future. [ABSTRACT FROM AUTHOR]